[Ãëàâíàÿ/Ïîèñê] [Ïðîèçâîäèòåëè] [Ìîñêâà] [Ñ-Ïá] [Äðóãèå] [Îáùèé] [Çàÿâêè] [Âûáîðêà]

Öåíû íà ÔÀËÈÌÈÍÒ ÄÐÀÆÅ 25ÌÃ ¹20 - ÔÓÖÈÒÀËÌÈÊ ÊÀÏËÈ ÃËÀÇÍÛÅ 1% 5Ã ¹1

Ïðîäàâåö: ÐÎÑÔÀÐÌÀÖÈß (Ìîñêâà, Ðåóòîâ, óë.Ôàáðè÷íàÿ ä.7 Òåë./ôàêñ:(495) 926-36-87 (495) 926-90-66)

ÍàèìåíîâàíèåÏðîèçâîäèòåëüÖåíà $Öåíà ðóá
ÔÀËÈÌÈÍÒ ÄÐÀÆÅ 25ÌÃ ¹20 (BERLIN-CHEMIE, ÃÅÐÌÀÍÈß)BERLIN-CHEMIE93.33
ÔÀÌÎÒÈÄÈÍ ÒÀÁ. 20ÌÃ ¹20 (ÁÈÎÊÎÌ ÇÀÎ, ÐÎÑÑÈß)ÁÈÎÊÎÌ ÇÀÎ8.89
ÔÀÌÎÒÈÄÈÍ ÒÀÁ. Ï/Î 20ÌÃ ¹30 (ÎÇÎÍ, ÐÎÑÑÈß)ÎÇÎÍ13.15
ÔÀÌÎÒÈÄÈÍ ÒÀÁ. Ï/Î 40ÌÃ ¹10 (ÎÇÎÍ, ÐÎÑÑÈß)ÎÇÎÍ8.56
ÔÀÌÎÒÈÄÈÍ ÒÀÁ. Ï/Î 40ÌÃ ¹20 (ÁÈÎÊÎÌ ÇÀÎ, ÐÎÑÑÈß)ÁÈÎÊÎÌ ÇÀÎ15.83
ÔÀÐÈÍÃÎÑÅÏÒ ÒÀÁ. 10ÌÃ ¹10 (TERAPIA S.A., ÐÓÌÛÍÈß)TERAPIA S.A.40.02
ÔÀÐÈÍÃÎÑÅÏÒ ÒÀÁ. 10ÌÃ ¹10 (ËÈÌÎÍ) (TERAPIA S.A., ÐÓÌÛÍÈß)TERAPIA S.A.38.85
ÔÀÐÈÍÃÎÑÅÏÒ ÒÀÁ. 10ÌÃ ¹20 (TERAPIA S.A., ÐÓÌÛÍÈß)TERAPIA S.A.58.94
ÔÀÐÈÍÃÎÑÅÏÒ ÒÀÁ. 10ÌÃ ¹20 (ËÈÌÎÍ) (TERAPIA S.A., ÐÓÌÛÍÈß)TERAPIA S.A.61.71
ÔÀÐÌÀÒÅÊÑ ÊÐÅÌ ÂÀÃÈÍÀËÜÍÛÉ 72Ã ¹1 (INNOTECH INTERNATIONAL, ÔÐÀÍÖÈß)INNOTECH INTERNATIONAL192.51
ÔÀÐÌÀÒÅÊÑ ÑÓÏÏ. ÂÀÃÈÍÀËÜÍÛÅ ¹10 (INNOTECH INTERNATIONAL, ÔÐÀÍÖÈß)INNOTECH INTERNATIONAL245.12
ÔÀÐÌÀÒÅÊÑ ÒÀÁ. ÂÀÃ. 20ÌÃ ¹12 (INNOTECH INTERNATIONAL, ÔÐÀÍÖÈß)INNOTECH INTERNATIONAL170.23
ÔÀÑÒÓÌ ÃÅËÜ 2,5% 30Ã ¹1 (BERLIN-CHEMIE/MENARINI, ÈÒÀËÈß)BERLIN-CHEMIE/MENARINI169.45
ÔÀÑÒÓÌ ÃÅËÜ 2,5% 50Ã ¹1 (BERLIN-CHEMIE/MENARINI, ÈÒÀËÈß)BERLIN-CHEMIE/MENARINI208.25
ÔÅÁÐÎÔÈÄ ÃÅËÜ 2,5% 30Ã ¹1 (MEDANA PHARMA TERPOL, ÏÎËÜØÀ)MEDANA PHARMA TERPOL130.36
ÔÅÁÐÎÔÈÄ ÃÅËÜ 2,5% 50Ã ¹1 (MEDANA PHARMA TERPOL, ÏÎËÜØÀ)MEDANA PHARMA TERPOL173.7
ÔÅÂÀÐÈÍ ÒÀÁ. Ï/Î 50ÌÃ ¹15 (SOLVAY PHARMACEUTICALS, ÔÐÀÍÖÈß)SOLVAY PHARMACEUTICALS545.38
ÔÅÇÀÌ ÊÀÏÑ. ¹60 (BALKANPHARMA, ÁÎËÃÀÐÈß)BALKANPHARMA130.69
ÔÅÊÑÀÄÈÍ ÒÀÁ. Ï/Î 120ÌÃ ¹10 (RANBAXY, ÈÍÄÈß)RANBAXY118.47
ÔÅÊÑÀÄÈÍ ÒÀÁ. Ï/Î 180ÌÃ ¹10 (RANBAXY, ÈÍÄÈß)RANBAXY185.49
ÔÅËÎÄÈÏ ÐÅÒÀÐÄ ÒÀÁ. 10Ìà ¹30 (IVAX PHARMACEUTICALS, ×ÅÕÈß)IVAX PHARMACEUTICALS515.65
ÔÅËÎÄÈÏ ÐÅÒÀÐÄ ÒÀÁ. Ï/Î 5Ìà ¹30 (IVAX PHARMACEUTICALS, ×ÅÕÈß)IVAX PHARMACEUTICALS331.67
ÔÅÌÈÍÀËÜÃÈÍ ÒÀÁ. ÃÎÌÅÎÏ. ¹20 (ÌÀÒÅÐÈÀ ÌÅÄÈÊÀ ÕÎËÄÈÍÃ, ÐÎÑÑÈß)ÌÀÒÅÐÈÀ ÌÅÄÈÊÀ ÕÎËÄÈÍÃ26.52
ÔÅÌÎÄÅÍ ÄÐÀÆÅ ¹21 (SCHERING A.G, ÃÅÐÌÀÍÈß)SCHERING A.G439.84
ÔÅÍÀÇÅÏÀÌ (ÝËÇÅÏÀÌ) Ð-Ð ÄËß Â/Â È Â/Ì ÂÂÅÄ. 0,1% 1ÌË ¹10 (ÝËËÀÐÀ, ÐÎÑÑÈß)ÝËËÀÐÀ103.1
ÔÅÍÀÇÅÏÀÌ Ð-Ð ÄËß Â/Â È Â/Ì ÂÂÅÄ. 0,1% 1ÌË ¹10 (ÍÎÂÎÑÈÁÕÈÌÔÀÐÌ, ÐÎÑÑÈß)ÍÎÂÎÑÈÁÕÈÌÔÀÐÌ116.82
ÔÅÍÀÇÅÏÀÌ ÒÀÁ. 0,5ÌÃ ¹50 (ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ, ÐÎÑÑÈß)ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ59.73
ÔÅÍÀÇÅÏÀÌ ÒÀÁ. 1ÌÃ ¹50 (ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ, ÐÎÑÑÈß)ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ75.89
ÔÅÍÀÇÅÏÀÌ ÒÀÁ. 2,5ÌÃ ¹50 (ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ, ÐÎÑÑÈß)ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ118.23
ÔÅÍÈÁÓÒ ÒÀÁ. 250ÌÃ ¹20 (ÁÅËÌÅÄÏÐÅÏÀÐÀÒÛ ÐÓÏ, ÁÅËÀÐÓÑÜ)ÁÅËÌÅÄÏÐÅÏÀÐÀÒÛ ÐÓÏ75.79
ÔÅÍÈÁÓÒ ÒÀÁ. 250ÌÃ ¹20 (ÎÇÎÍ, ÐÎÑÑÈß)ÎÇÎÍ75.45
ÔÅÍÈÃÈÄÈÍ ÒÀÁ. 10ÌÃ ¹50 (ËÓÃÀÍÑÊÈÉ ÕÔÇ, ÓÊÐÀÈÍÀ)ËÓÃÀÍÑÊÈÉ ÕÔÇ6.59
ÔÅÍÈËÈÍ ÒÀÁ. 30ÌÃ ¹20 (ÇÄÎÐÎÂÜÅ ÔÊ, ÓÊÐÀÈÍÀ)ÇÄÎÐÎÂÜÅ ÔÊ51.78
ÔÅÍÈÑÒÈË ÃÅËÜ 0,1% 30Ã ¹1 (NOVARTIS CONSUMER HEALTH, ØÂÅÉÖÀÐÈß)NOVARTIS CONSUMER HEALTH196.81
ÔÅÍÈÑÒÈË ÃÅËÜ Ä/ÍÀÐÓÆÍ.ÏÐÈÌ. 0,1% 50Ã N1 (NOVARTIS CONSUMER HEALTH, ØÂÅÉÖÀÐÈß)NOVARTIS CONSUMER HEALTH211.72
ÔÅÍÈÑÒÈË ÊÀÏËÈ 0,1% 20ÌË ¹1 (NOVARTIS CONSUMER HEALTH, ØÂÅÉÖÀÐÈß)NOVARTIS CONSUMER HEALTH213.52
ÔÅÍÈÑÒÈË ÏÅÍÖÈÂÈÐ ÊÐÅÌ 1% 2Ã ¹1 (NOVARTIS CONSUMER HEALTH, ÃÅÐÌÀÍÈß)NOVARTIS CONSUMER HEALTH207.24
ÔÅÍÊÀÐÎË ÒÀÁ. 10ÌÃ ¹20 (ÎËÀÉÍÔÀÐÌ, ËÀÒÂÈß)ÎËÀÉÍÔÀÐÌ102.17
ÔÅÍÊÀÐÎË ÒÀÁ. 25ÌÃ ¹20 (ÎËÀÉÍÔÀÐÌ, ËÀÒÂÈß)ÎËÀÉÍÔÀÐÌ146.97
ÔÅÍÎÁÀÐÁÈÒÀË ÒÀÁ. 100ÌÃ ¹10 (ÀÑÔÀÐÌÀ ÎÎÎ, ÐÎÑÑÈß)ÀÑÔÀÐÌÀ ÎÎÎ7.36
ÔÅÍÎÊÑÈÌÅÒÈËÏÅÍÈÖÈËËÈÍ ÒÀÁ. 250ÌÃ ¹10 (ÑÈÍÒÅÇ ÀÊÎÌÏ, ÐÎÑÑÈß)ÑÈÍÒÅÇ ÀÊÎÌÏ13.29
ÔÅÍÎÒÐÎÏÈË ÒÀÁ. 100ÌÃ ¹10 (ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ, ÐÎÑÑÈß)ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ311.45
ÔÅÍÎÒÐÎÏÈË ÒÀÁ. 100ÌÃ ¹30 (ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ, ÐÎÑÑÈß)ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ754.07
ÔÅÍÕÅËß ÏËÎÄÛ 50à ¹1 (ÈÂÀÍ-×ÀÉ ÇÀÎ, ÐÎÑÑÈß)ÈÂÀÍ-×ÀÉ ÇÀÎ16.87
ÔÅÍÞËÜÑ ÊÀÏÑ. ¹10 (RANBAXY, ÈÍÄÈß)RANBAXY41.83
ÔÅÍÞËÜÑ ÊÀÏÑ. ¹30 (RANBAXY, ÈÍÄÈß)RANBAXY80.73
ÔÅÐÂÅÊÑ ÄËß ÄÅÒÅÉ ÏÎÐÎØÎÊ ¹8 (BRISTOL MYERS SQUIBB, ÑØÀ)BRISTOL MYERS SQUIBB128.61
ÔÅÐÂÅÊÑ ÏÎÐ.Á/ÑÀÕ. ¹8 (ËÈÌÎÍ) (BRISTOL MYERS SQUIBB, ÔÐÀÍÖÈß)BRISTOL MYERS SQUIBB137.08
ÔÅÐÂÅÊÑ ÏÎÐ.Ñ ÑÀÕ. ¹8 (ËÈÌÎÍ) (BRISTOL MYERS SQUIBB, ÔÐÀÍÖÈß)BRISTOL MYERS SQUIBB137.03
ÔÅÐÂÅÊÑ ÏÎÐÎØÎÊ ¹8 (ÌÀËÈÍÀ) (BRISTOL MYERS SQUIBB, ÔÐÀÍÖÈß)BRISTOL MYERS SQUIBB137.75
ÔÅÐËÀÒÓÌ Ð-Ð Ä/ÂÍÓÒÐ.ÏÐÈÌ. 800ÌÃ/15ÌË ¹10 (ITALFARMACO, ÈÒÀËÈß)ITALFARMACO438.69
ÔÅÐÎÃËÎÁÈÍ Â-12 ÑÈÐÎÏ 200ÌË ¹1 (VITABIOTICS LTD, ÃÅÐÌÀÍÈß)VITABIOTICS LTD257.25
ÔÅÐÐÅÒÀÁ ÊÎÌÏ ÊÀÏÑ. ÏÐÎËÎÍÃ.ÄÅÉÑÒÂ. ¹30 (LANNACHER HEILMITTEL GMBH, ÀÂÑÒÐÈß)LANNACHER HEILMITTEL GMBH67.95
ÔÅÐÐÎ-ÔÎËÜÃÀÌÌÀ ÊÀÏÑ. ¹20 (WOERWAG PHARMA GMBH, ÃÅÐÌÀÍÈß)WOERWAG PHARMA GMBH107.82
ÔÅÐÐÎ-ÔÎËÜÃÀÌÌÀ ÊÀÏÑ. ¹20 (Ñ.Ï.Ì. ÊÎÍÒÐÀÊÒ ÔÀÐÌÀ ÃÌÁÕ È ÊÎ ÊÃ, ÃÅÐÌÀÍÈß)Ñ.Ï.Ì. ÊÎÍÒÐÀÊÒ ÔÀÐÌÀ ÃÌÁÕ È ÊÎ ÊÃ107.3
ÔÅÐÐÓÌ ËÅÊ Ð-Ð ÄËß Â/Ì ÂÂÅÄ. 2ÌË ¹5 (LEK, ÑËÎÂÅÍÈß)LEK436.15
ÔÅÐÐÓÌ ËÅÊ Ð-Ð ÄËß Â/Ì ÂÂÅÄ. 2ÌË ¹50 (LEK, ÑËÎÂÅÍÈß)LEK4225.32
ÔÅÐÐÓÌ ËÅÊ ÑÈÐÎÏ 50ÌÃ / 5ÌË 100ÌË ¹1 (LEK, ÑËÎÂÅÍÈß)LEK135.72
ÔÅÐÐÓÌ ËÅÊ ÒÀÁ. ÆÅÂÀÒ. 100ÌÃ ¹30 (LEK, ÑËÎÂÅÍÈß)LEK272.33
ÔÅÑÒÀË ÄÐÀÆÅ ¹100 (AVENTIS PHARMA, ÈÍÄÈß)AVENTIS PHARMA299.7
ÔÅÑÒÀË ÄÐÀÆÅ ¹20 (AVENTIS PHARMA, ÈÍÄÈß)AVENTIS PHARMA58.28
ÔÈÀËÊÈ ÒÐÅÕÖÂÅÒÍÎÉ ÒÐÀÂÀ 1,5Ã ¹20 Ô/ÏÀÊ. (ÊÐÀÑÍÎÃÎÐÑÊËÅÊÑÐÅÄÑÒÂÀ ÎÀÎ, ÐÎÑÑÈß)ÊÐÀÑÍÎÃÎÐÑÊËÅÊÑÐÅÄÑÒÂÀ ÎÀÎ38.25
ÔÈÀËÊÈ ÒÐÅÕÖÂÅÒÍÎÉ ÒÐÀÂÀ 50Ã ¹1 (ÇÄÎÐÎÂÜÅ, ÐÎÑÑÈß)ÇÄÎÐÎÂÜÅ29.47
ÔÈÇÈÎÌÅÐ ÑÏÐÅÉ ÍÀÇ. 135ÌË ¹1 (LABORATOIRES GOEMAR S.A., ÔÐÀÍÖÈß)LABORATOIRES GOEMAR S.A.305.56
ÔÈÇÈÎÌÅÐ ÑÏÐÅÉ ÍÀÇ. 210ÌË ¹1 (LABORATOIRES GOEMAR S.A., ÔÐÀÍÖÈß)LABORATOIRES GOEMAR S.A.330.33
ÔÈÇÈÎÌÅÐ ÑÏÐÅÉ ÍÀÇ.Ä/Ä 115ÌË ¹1 (LABORATOIRES GOEMAR S.A., ÔÐÀÍÖÈß)LABORATOIRES GOEMAR S.A.263.61
ÔÈÇÈÎÌÅÐ ÔÎÐÒÅ ÑÏÐÅÉ ÍÀÇ. 210ÌË ¹1 (LABORATOIRES GOEMAR S.A., ÔÐÀÍÖÈß)LABORATOIRES GOEMAR S.A.325.67
ÔÈÇÈÎÒÅÍÇ ÒÀÁ. Ï/Î 0,2ÌÃ ¹14 (ROTTENDORF PHARMA/SOLVAY, ÔÐÀÍÖÈß)ROTTENDORF PHARMA/SOLVAY245.15
ÔÈÇÈÎÒÅÍÇ ÒÀÁ. Ï/Î 0,4ÌÃ ¹14 (SOLVAY PHARMA, ÃÅÐÌÀÍÈß)SOLVAY PHARMA380.12
ÔÈÊÑÀÒÎÐ ÀÍÀÒÎÌÈ×.ÏÎÄÃ.SAN SENI EX.LARGE ¹2 (TZMO SA, ÏÎËÜØÀ)TZMO SA72.16
ÔÈÊÑÀÒÎÐ ÀÍÀÒÎÌÈ×.ÏÎÄÃ.SAN SENI LARGE ¹2 (TZMO SA, ÏÎËÜØÀ)TZMO SA66.27
ÔÈËÜÒÐÓÌ-ÑÒÈ ÒÀÁ. 400ÌÃ ¹10 (ÑÒÈ-ÌÅÄ-ÑÎÐÁ, ÐÎÑÑÈß)ÑÒÈ-ÌÅÄ-ÑÎÐÁ52.93
ÔÈËÜÒÐÓÌ-ÑÒÈ ÒÀÁ. 400ÌÃ ¹50 (ÑÒÈ-ÌÅÄ-ÑÎÐÁ, ÐÎÑÑÈß)ÑÒÈ-ÌÅÄ-ÑÎÐÁ137.4
ÔÈËÜÒÐÓÌ-ÑÒÈ ÒÀÁ. 400ÌÃ ¹50 (ÑÒÈ-ÌÅÄ-ÑÎÐÁ/ÀÂÂÀ ÐÓÑ, ÐÎÑÑÈß)ÑÒÈ-ÌÅÄ-ÑÎÐÁ/ÀÂÂÀ ÐÓÑ141.88
ÔÈÍÀËÃÅËÜ ÃÅËÜ 0,5% 35Ã ¹1 (BOEHRINGER INGELHEIM, ÃÅÐÌÀÍÈß)BOEHRINGER INGELHEIM188.84
ÔÈÍÀËÃÎÍ ÌÀÇÜ 20Ã ¹1 (BOEHRINGER INGELHEIM, ÃÅÐÌÀÍÈß)BOEHRINGER INGELHEIM184.67
ÔÈÍÀÑÒ ÒÀÁ. Ï/Î 5ÌÃ ¹30 (DR. REDDYS LAB., ÈÍÄÈß)DR. REDDYS LAB.308.67
ÔÈÍËÅÏÑÈÍ ÐÅÒÀÐÄ ÒÀÁ. 200ÌÃ ¹50 (AWD, ÃÅÐÌÀÍÈß)AWD166.54
ÔÈÍËÅÏÑÈÍ ÐÅÒÀÐÄ ÒÀÁ. 200ÌÃ ¹50 (PLIVA, ÏÎËÜØÀ)PLIVA165.05
ÔÈÍËÅÏÑÈÍ ÒÀÁ. 200ÌÃ ¹50 (AWD, ÃÅÐÌÀÍÈß)AWD205.24
ÔÈÍËÅÏÑÈÍ ÒÀÁ. ÏÐÎËÎÍÃ.ÄÅÉÑÒÂ. 200ÌÃ ¹50 (AWD, ÃÅÐÌÀÍÈß)AWD162.65
ÔÈÍËÅÏÑÈÍ ÒÀÁ. ÐÅÒÀÐÄ 400ÌÃ ¹50 (AWD, ÃÅÐÌÀÍÈß)AWD245.23
ÔÈÒÎËÀÊÑ ÒÀÁ. 0,5Ã ¹20 (ÝÂÀËÀÐ, ÐÎÑÑÈß)ÝÂÀËÀÐ73.84
ÔÈÒÎÑÛÂÎÐÎÒÊÀ ÂÎÇÐÎÆÄÅÍÈÅ È ÓÊÐÅÏ. ÎÑËÀÁ. ÂÎËÎÑ Ñ ÂÈÒ.Ä È ÊÎËËÀÃÅÍÎÌ 100ÌË ¹1 (ËÅÊÎÌÀÊÑ ÔÀÐÌÀ, ÐÎÑÑÈß)ËÅÊÎÌÀÊÑ ÔÀÐÌÀ140.8
ÔËÀÌÈÍ ÃÐÀÍÓËÛ Ä/Ä 1,38Ã ¹20 (ÂÈÔÈÒÅÕ ÇÀÎ, ÐÎÑÑÈß)ÂÈÔÈÒÅÕ ÇÀÎ57.32
ÔËÀÌÈÍ ÒÀÁ. 50ÌÃ ¹10 (ÂÈÔÈÒÅÕ ÇÀÎ, ÐÎÑÑÈß)ÂÈÔÈÒÅÕ ÇÀÎ32.32
ÔËÀÌÈÍ ÒÀÁ. 50ÌÃ ¹30 (ÇÄÎÐÎÂÜÅ, ÓÊÐÀÈÍÀ)ÇÄÎÐÎÂÜÅ57.92
ÔËÅÁÎÄÈÀ 600 ÒÀÁ. Ï/Î 600ÌÃ ¹30 (INNOTECH INTERNATIONAL, ÔÐÀÍÖÈß)INNOTECH INTERNATIONAL552.17
ÔËÅÊÑÅÍ ÃÅËÜ 2,5% 30Ã ¹1 (ITALFARMACO, ÈÒÀËÈß)ITALFARMACO121.81
ÔËÅÌÎÊËÀÂ ÑÎËÞÒÀÁ ÒÀÁ. 500ÌÃ+125ÌÃ ¹20 (ASTELLAS PHARMA EUROPE B.V./ÎÐÒÀÒ, ÐÎÑÑÈß)ASTELLAS PHARMA EUROPE B.V./ÎÐÒÀÒ468.64
ÔËÅÌÎÊËÀÂ ÑÎËÞÒÀÁ ÒÀÁ. ÄÈÑÏ. 500ÌÃ+125ÌÃ ¹20 (ASTELLAS PHARMA EUROPE B.V./ÎÐÒÀÒ, ÍÈÄÅÐËÀÍÄÛ/ÐÎÑÑÈß)ASTELLAS PHARMA EUROPE B.V./ÎÐÒÀÒ486.52
ÔËÅÌÎÊÑÈÍ ÑÎËÞÒÀÁ ÒÀÁ. ÄÈÑÏ. 1000ÌÃ ¹20 (ASTELLAS PHARMA EUROPE B.V./ÎÐÒÀÒ, ÍÈÄÅÐËÀÍÄÛ/ÐÎÑÑÈß)ASTELLAS PHARMA EUROPE B.V./ÎÐÒÀÒ337.94
ÔËÅÌÎÊÑÈÍ ÑÎËÞÒÀÁ ÒÀÁ. ÄÈÑÏ. 1000ÌÃ ¹20 (YAMANOUCHI/ÎÐÒÀÒ, ÍÈÄÅÐËÀÍÄÛ/ÐÎÑÑÈß)YAMANOUCHI/ÎÐÒÀÒ354.56
ÔËÅÌÎÊÑÈÍ ÑÎËÞÒÀÁ ÒÀÁ. ÄÈÑÏ. 125ÌÃ ¹20 (ASTELLAS PHARMA EUROPE B.V., ÍÈÄÅÐËÀÍÄÛ)ASTELLAS PHARMA EUROPE B.V.164.8
ÔËÅÌÎÊÑÈÍ ÑÎËÞÒÀÁ ÒÀÁ. ÄÈÑÏ. 500ÌÃ ¹20 (ASTELLAS PHARMA EUROPE B.V./ÎÐÒÀÒ, ÐÎÑÑÈß)ASTELLAS PHARMA EUROPE B.V./ÎÐÒÀÒ249.33
ÔËÈÊÑÎÍÀÇÅ ÑÏÐÅÉ ÍÀÇ. 50ÌÊÃ 120ÄÎÇ ¹1 (GLAXOSMITHKLINE PHARMACEUTICALS, ÏÎËÜØÀ)GLAXOSMITHKLINE PHARMACEUTICALS553.65
ÔËÈÊÑÎÍÀÇÅ ÑÏÐÅÉ ÍÀÇ. 50ÌÊÃ/ÄÎÇÀ 120 ÄÎÇ ¹1 (GLAXO SMITH KLINE, ÏÎËÜØÀ)GLAXO SMITH KLINE587.54
ÔËÈÊÑÎÒÈÄ ÀÝÐÎÇÎËÜ 125ÌÊÃ/ÄÎÇÀ 60 ÄÎÇ ¹1 (GLAXO SMITH KLINE, ÏÎËÜØÀ)GLAXO SMITH KLINE630.29
ÔËÈÊÑÎÒÈÄ ÀÝÐÎÇÎËÜ 250ÌÊÃ/ÄÎÇÀ 60 ÄÎÇ ¹1 (GLAXO SMITH KLINE, ÏÎËÜØÀ)GLAXO SMITH KLINE905.58
ÔËÈÊÑÎÒÈÄ ÀÝÐÎÇÎËÜ 50ÌÊÃ/ÄÎÇÀ 120 ÄÎÇ ¹1 (GLAXO SMITH KLINE, ÏÎËÜØÀ)GLAXO SMITH KLINE166.02
ÔËÈÊÑÎÒÈÄ ÀÝÐÎÇÎËÜ 50ÌÊÃ/ÄÎÇÀ 120 ÄÎÇ ¹1 (GLAXO SMITH KLINE, ÏÎËÜØÀ)GLAXO SMITH KLINE394.77
ÔËÈÒ ÔÎÑÔÎ-ÑÎÄÀ Ð-Ð Ä/ÂÍÓÒÐ.ÏÐÈÌ. 45ÌË ¹2 (LABORATORIOS CASEN FLEET, ÃÅÐÌÀÍÈß)LABORATORIOS CASEN FLEET715.82
ÔËÎÃÝÍÇÈÌ ÒÀÁ. Ï/Î ¹100 (MUCOS PHARMA, ÃÅÐÌÀÍÈß)MUCOS PHARMA1251.23
ÔËÎÃÝÍÇÈÌ ÒÀÁ. Ï/Î ¹40 (MUCOS PHARMA, ÃÅÐÌÀÍÈß)MUCOS PHARMA544.09
ÔËÎÊÑÀË ÊÀÏËÈ ÃËÀÇÍÛÅ 0,3% 5ÌË ¹1 (DR. GERHARD MANN CHEM. - PHARM.FABRIK, ÃÅÐÌÀÍÈß)DR. GERHARD MANN CHEM. - PHARM.FABRIK161.85
ÔËÎÊÑÀË ÌÀÇÜ ÃËÀÇÍÀß 0,3% 3Ã ¹1 (BAUSCH & LOMB, ÃÅÐÌÀÍÈß)BAUSCH & LOMB178.44
ÔËÎÐÀÖÈÄ ÒÀÁ. Ï/Î 250ÌÃ ¹5 (ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ, ÐÎÑÑÈß)ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ238.76
ÔËÎÐÀÖÈÄ ÒÀÁ. Ï/Î 500ÌÃ ¹5 (ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ/ÎÁÎËÅÍÑÊÎÅ, ÐÎÑÑÈß)ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ/ÎÁÎËÅÍÑÊÎÅ432.91
ÔËÎÐÈÍ ÔÎÐÒÅ ÏÎÐ.Ä/ÂÍÓÒÐ.ÏÐÈÌ. ¹30 (ÏÀÐÒÍÅÐ, ÐÎÑÑÈß)ÏÀÐÒÍÅÐ481.8
ÔËÓÈÌÓÖÈË ÀÍÒÈÁÈÎÒÈÊ ÈÒ ÏÎÐ. Ä/ÈÍ 500ÌÃ ¹3 +Ð-ËÜ (ZAMBON GROUP, ÈÒÀËÈß)ZAMBON GROUP366
ÔËÓÈÌÓÖÈË ÃÐÀÍÓËÛ Ä/ÏÐÈÃ.Ð-ÐÀ Ä/ÂÍÓÒÐ.ÏÐÈÌ. 200ÌÃ 1Ã ¹20 (ZAMBON GROUP, ØÂÅÉÖÀÐÈß)ZAMBON GROUP148.55
ÔËÓÈÌÓÖÈË Ð-Ð Ä/ÈÍ. 300ÌÃ 3ÌË ¹5 (ZAMBON GROUP, ÈÒÀËÈß)ZAMBON GROUP187.48
ÔËÓÈÌÓÖÈË ÒÀÁ. ØÈÏÓ×ÈÅ 600Ìà ¹10 (ZAMBON GROUP, ØÂÅÉÖÀÐÈß)ZAMBON GROUP114.41
ÔËÓÈÔÎÐÒ ÃÐÀÍÓËÛ Ä/ÏÐÈÃ.ÑÓÑÏ.Ä/ÂÍÓÒÐ.ÏÐÈÌ. 5Ã ¹10 (DOMPE FARMACEUTICI S.P.A., ÈÒÀËÈß)DOMPE FARMACEUTICI S.P.A.279.79
ÔËÓÊÎÍÀÇÎË ÊÀÏÑ. 150ÌÃ ¹1 (ÁÈÎÊÎÌ ÇÀÎ, ÐÎÑÑÈß)ÁÈÎÊÎÌ ÇÀÎ21.38
ÔËÓÊÎÍÀÇÎË ÊÀÏÑ. 150ÌÃ ¹1 (ÎÁÎËÅÍÑÊÎÅ, ÐÎÑÑÈß)ÎÁÎËÅÍÑÊÎÅ20.97
ÔËÓÊÎÍÀÇÎË ÊÀÏÑ. 150ÌÃ ¹1 (ÎÇÎÍ, ÐÎÑÑÈß)ÎÇÎÍ16.2
ÔËÓÊÎÍÀÇÎË ÊÀÏÑ. 50ÌÃ ¹7 (ÁÈÎÊÎÌ ÇÀÎ, ÐÎÑÑÈß)ÁÈÎÊÎÌ ÇÀÎ40.79
ÔËÓÊÎÍÀÇÎË ÊÀÏÑ. 50ÌÃ ¹7 (ÎÇÎÍ, ÐÎÑÑÈß)ÎÇÎÍ43.02
ÔËÓÎÊÑÅÒÈÍ ÊÀÏÑ. 10ÌÃ ¹20 (ÁÈÎÊÎÌ ÇÀÎ, ÐÎÑÑÈß)ÁÈÎÊÎÌ ÇÀÎ46.34
ÔËÓÎÊÑÅÒÈÍ ÊÀÏÑ. 20ÌÃ ¹20 (ÁÈÎÊÎÌ ÇÀÎ, ÐÎÑÑÈß)ÁÈÎÊÎÌ ÇÀÎ60.9
ÔËÓÎÊÑÅÒÈÍ ÊÀÏÑ. 20ÌÃ ¹20 (ÎÇÎÍ, ÐÎÑÑÈß)ÎÇÎÍ42.84
ÔËÓÎÊÑÅÒÈÍ ÊÀÏÑ. 20ÌÃ ¹30 (ÀËÑÈ ÔÀÐÌÀ ÇÀÎ, ÐÎÑÑÈß)ÀËÑÈ ÔÀÐÌÀ ÇÀÎ66.55
ÔËÓÖÈÍÀÐ ÃÅËÜ 0,025% 15Ã ¹1 (JELFA, ÏÎËÜØÀ)JELFA94.16
ÔËÓÖÈÍÀÐ ÌÀÇÜ 0,025% 15Ã ¹1 (JELFA, ÏÎËÜØÀ)JELFA109.78
ÔËÓÖÈÍÀÐ Í ÌÀÇÜ 15Ã ¹1 (JELFA, ÏÎËÜØÀ)JELFA84.36
ÔËÞÀÍÊÑÎË Ð-Ð Ä/ÈÍ.ÌÀÑË. 20ÌÃ/ÌË 1ÌË ¹10 (H LUNDBECK, ÄÀÍÈß)H LUNDBECK2035.7
ÔËÞÀÍÊÑÎË ÒÀÁ. Ï/Î 0,5ÌÃ ¹50 (H LUNDBECK, ÄÀÍÈß)H LUNDBECK290.88
ÔËÞÀÍÊÑÎË ÒÀÁ. Ï/Î 1ÌÃ ¹50 (H LUNDBECK, ÄÀÍÈß)H LUNDBECK429.68
ÔËÞÀÍÊÑÎË ÒÀÁ. Ï/Î 5ÌÃ ¹100 (H LUNDBECK, ÄÀÍÈß)H LUNDBECK1081.34
ÔËÞÄÈÒÅÊ ÑÈÐÎÏ 2% 125ÌË ¹1 (INNOTHERA CHOUZY, ÔÐÀÍÖÈß)INNOTHERA CHOUZY148.04
ÔËÞÄÈÒÅÊ ÑÈÐÎÏ 5% 125ÌË ¹1 (INNOTHERA CHOUZY, ÔÐÀÍÖÈß)INNOTHERA CHOUZY145.04
ÔËÞÊÎËÄÅÊÑ-Í ÒÀÁ. ¹12 (NABROS PHARMA, ÈÍÄÈß)NABROS PHARMA52.4
ÔËÞÊÎÑÒÀÒ ÊÀÏÑ. 150ÌÃ ¹1 (ÔÀÐÌÑÒÀÍÄÀÐÒ-ËÅÊÑÐÅÄÑÒÂÀ, ÐÎÑÑÈß)ÔÀÐÌÑÒÀÍÄÀÐÒ-ËÅÊÑÐÅÄÑÒÂÀ143.31
ÔËÞÊÎÑÒÀÒ ÊÀÏÑ. 50ÌÃ ¹7 (ÔÀÐÌÑÒÀÍÄÀÐÒ-ËÅÊÑÐÅÄÑÒÂÀ, ÐÎÑÑÈß)ÔÀÐÌÑÒÀÍÄÀÐÒ-ËÅÊÑÐÅÄÑÒÂÀ224
ÔÎÇÈÊÀÐÄ ÒÀÁ. 10ÌÃ ¹28 (ACTAVIS, ÁÎËÃÀÐÈß)ACTAVIS137.99
ÔÎÇÈÊÀÐÄ ÒÀÁ. 20ÌÃ ¹28 (ACTAVIS, ÁÎËÃÀÐÈß)ACTAVIS165.21
ÔÎÇÈÊÀÐÄ ÒÀÁ. 20ÌÃ ¹28 (ACTAVIS, ÈÑËÀÍÄÈß)ACTAVIS147.46
ÔÎÊÓÑÈÍ ÊÀÏÑ. 0,4ÌÃ ¹30 (ZENTIVA A.S., ÑËÎÂÀÊÈß)ZENTIVA A.S.521.42
ÔÎËÀÖÈÍ ÒÀÁ. 5ÌÃ ¹30 (JADRAN, ÕÎÐÂÀÒÈß)JADRAN100.89
ÔÎËÈÅÂÀß ÊÈÑËÎÒÀ ÒÀÁ. 1ÌÃ ¹50 (ÁÎÐÈÑÎÂÑÊÈÉ ÇÌÏ, ÁÅËÀÐÓÑÜ)ÁÎÐÈÑÎÂÑÊÈÉ ÇÌÏ18.26
ÔÎËÈÅÂÀß ÊÈÑËÎÒÀ ÒÀÁ. 1ÌÃ ¹50 (ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ, ÐÎÑÑÈß)ÂÀËÅÍÒÀ ÔÀÐÌÀÖÅÂÒÈÊÀ19.3
ÔÎËÈÅÂÀß ÊÈÑËÎÒÀ ÒÀÁ. 1ÌÃ ¹50 (ÎÇÎÍ, ÐÎÑÑÈß)ÎÇÎÍ18.73
ÔÎÐÀÄÈË ÊÀÏÑ. 12ÌÊÃ ¹30 (NOVARTIS PHARMA, ØÂÅÉÖÀÐÈß)NOVARTIS PHARMA677.05
ÔÎÐËÀÊÑ ÏÎÐ.Ä/Ä 4Ã ¹20 (BEAUFOUR IPSEN, ÔÐÀÍÖÈß)BEAUFOUR IPSEN226.97
ÔÎÐËÀÊÑ ÏÎÐÎØÎÊ 10Ã ¹10 (BEAUFOUR IPSEN, ÔÐÀÍÖÈß)BEAUFOUR IPSEN129.72
ÔÎÐËÀÊÑ ÏÎÐÎØÎÊ 10Ã ¹20 (BEAUFOUR IPSEN, ÔÐÀÍÖÈß)BEAUFOUR IPSEN240.15
ÔÎÐÌÈÄÐÎÍ Ð-Ð Ä/ÍÀÐÓÆ.ÏÐÈÌ. 100ÌË (ÒÓËÜÑÊÀß ÔÀÐÌ.ÔÀÁÐÈÊÀ, ÐÎÑÑÈß)ÒÓËÜÑÊÀß ÔÀÐÌ.ÔÀÁÐÈÊÀ12.94
ÔÎÐÌÈÄÐÎÍ Ð-Ð Ä/ÍÀÐÓÆÍ.ÏÐÈÌ. 50ÌË ¹1 (ÒÂÅÐÑÊÀß ÔÀÐÌÔÀÁÐÈÊÀ, ÐÎÑÑÈß)ÒÂÅÐÑÊÀß ÔÀÐÌÔÀÁÐÈÊÀ5.8
ÔÎÐÌÓËÀ ÑÍÀ ÒÀÁ. 500ÌÃ ¹40 (ÝÂÀËÀÐ, ÐÎÑÑÈß)ÝÂÀËÀÐ73.04
ÔÎÐÒÐÀÍÑ ÏÎÐÎØÎÊ 64Ã ¹4 (BEAUFOUR IPSEN, ÔÐÀÍÖÈß)BEAUFOUR IPSEN506.52
ÔÎÐÒÓÌ ÏÎÐ.Ä/ÏÐÈÃ.Ð-ÐÀ Ä/ÈÍ. 1Ã ¹1 (GLAXO SMITH KLINE, ÈÒÀËÈß)GLAXO SMITH KLINE337.57
ÔÎÐÒÓÌ ÏÎÐ.Ä/ÏÐÈÃ.Ð-ÐÀ Ä/ÈÍ. 2Ã ¹1 (GLAXO SMITH KLINE, ÈÒÀËÈß)GLAXO SMITH KLINE460.64
ÔÎÑÔÀËÞÃÅËÜ ÃÅËÜ Ä/ÂÍÓÒÐ.ÏÐÈÌ. 16Ã ¹20 (YAMANOUCHI/PHARMATIS, ÔÐÀÍÖÈß)YAMANOUCHI/PHARMATIS189.27
ÔÎÑÔÎÃËÈÂ ËÈÎÔ.Ä/ÏÐÈÃ.Ð-ÐÀ ÄËß Â/Â ÂÂÅÄ. 2,5Ã ¹5 (ÔÀÐÌÑÒÀÍÄÀÐÒ-ÓÔÀÂÈÒÀ, ÐÎÑÑÈß)ÔÀÐÌÑÒÀÍÄÀÐÒ-ÓÔÀÂÈÒÀ1224.19
ÔÎÒÈË ÊÀÏËÈ ÃËÀÇÍÛÅ 5ÌË ¹1 (SANTEN, ÔÈÍËßÍÄÈß)SANTEN131.34
ÔÎÒÈË ÔÎÐÒÅ ÊÀÏËÈ ÃËÀÇÍÛÅ 5ÌË ¹1 (SANTEN, ÔÈÍËßÍÄÈß)SANTEN134.61
ÔÐÀÃÌÈÍ Ð-Ð Ä/ÈÍ. 2500 ÌÅ 0,2ÌË ¹10 (PFIZER/VETTER PHARMA-FERTIGUNG FOR PHARMACIA, ÃÅÐÌÀÍÈß)PFIZER/VETTER PHARMA-FERTIGUNG FOR PHARMACIA1965.03
ÔÐÀÃÌÈÍ Ð-Ð Ä/ÈÍ. 5000 ÌÅ 0,2ÌË ¹10 (PFIZER/PHARMACIA&UPJOHN, ÃÅÐÌÀÍÈß)PFIZER/PHARMACIA&UPJOHN2594.23
ÔÐÀÊÑÈÏÀÐÈÍ Ð-Ð Ä/ÈÍ. 9500ÌÅ (2850ÌÅ) 0,3ÌË ¹10 ØÏÐÈÖ (GLAXO WELLCOME, ÔÐÀÍÖÈß)GLAXO WELLCOME1522.35
ÔÐÀÊÑÈÏÀÐÈÍ Ð-Ð Ä/ÈÍ. 9500ÌÅ (5700ÌÅ) 0,6ÌË ¹10 ØÏÐÈÖ (GLAXO WELLCOME, ÔÐÀÍÖÈß)GLAXO WELLCOME2752.66
ÔÐÈÄÅÐÌ ÄÅÃÎÒÜ ØÀÌÏÓÍÜ 150ÌË ¹1 (SCHERING PLOUGH, ÃÅÐÌÀÍÈß)SCHERING PLOUGH385.96
ÔÐÎÌÈËÈÄ ÒÀÁ. 250ÌÃ ¹14 (KRKA, ÑËÎÂÅÍÈß)KRKA134.63
ÔÐÎÌÈËÈÄ ÒÀÁ. 500ÌÃ ¹14 (KRKA, ÑËÎÂÅÍÈß)KRKA492.66
ÔÐÓÊÒÎÇÀ ÍÎÂÀÑÂÈÒ 500 Ã (ÍÎÂÀ ÏÐÎÄÓÊÒ ÀÃ ÎÎÎ, ÐÎÑÑÈß)ÍÎÂÀ ÏÐÎÄÓÊÒ ÀÃ ÎÎÎ59.75
ÔÒÀËÀÇÎË ÒÀÁ. 500ÌÃ ¹10 (ÈÐÁÈÒÑÊÈÉ ÕÔÇ, ÐÎÑÑÈß)ÈÐÁÈÒÑÊÈÉ ÕÔÇ8.92
ÔÒÎÐÎÊÎÐÒ ÌÀÇÜ 0,1% 15Ã ¹1 (GEDEON RICHTER, ÂÅÍÃÐÈß)GEDEON RICHTER125.56
ÔÓÇÈÄÈÍ-ÍÀÒÐÈß ÒÀÁ. 125ÌÃ ¹20 (ÁÈÎÑÈÍÒÅÇ, ÐÎÑÑÈß)ÁÈÎÑÈÍÒÅÇ350.86
ÔÓÊÎÐÖÈÍ Ð-Ð Ä/ÍÀÐÓÆÍ.ÏÐÈÌ.ÑÏÈÐÒ. 10ÌË ¹1 (ßÐÎÑËÀÂÑÊÀß ÔÀÐÌ.ÔÀÁÐÈÊÀ, ÐÎÑÑÈß)ßÐÎÑËÀÂÑÊÀß ÔÀÐÌ.ÔÀÁÐÈÊÀ7.74
ÔÓÊÎÐÖÈÍ Ð-Ð Ä/ÍÀÐÓÆÍ.ÏÐÈÌ.ÑÏÈÐÒ. 25ÌË ¹1 (ÒÓËÜÑÊÀß ÔÀÐÌ.ÔÀÁÐÈÊÀ, ÐÎÑÑÈß)ÒÓËÜÑÊÀß ÔÀÐÌ.ÔÀÁÐÈÊÀ9.71
ÔÓÍÃÎÒÅÐÁÈÍ ÊÐÅÌ 1% 15Ã ¹1 (ÍÈÆÔÀÐÌ, ÐÎÑÑÈß)ÍÈÆÔÀÐÌ158.66
ÔÓÍÃÎÒÅÐÁÈÍ ÒÀÁ. 250ÌÃ ¹10 (ÍÈÆÔÀÐÌ, ÐÎÑÑÈß)ÍÈÆÔÀÐÌ398.71
ÔÓÐÀÃÈÍ ÒÀÁ. 50ÌÃ ¹10 (ÎÁÎËÅÍÑÊÎÅ, ÐÎÑÑÈß)ÎÁÎËÅÍÑÊÎÅ12.92
ÔÓÐÀÃÈÍ ÒÀÁ. 50ÌÃ ¹30 (ÎÁÎËÅÍÑÊÎÅ, ÐÎÑÑÈß)ÎÁÎËÅÍÑÊÎÅ32.18
ÔÓÐÀÃÈÍ ÒÀÁ. 50ÌÃ ¹30 (ÎËÀÉÍÔÀÐÌ, ËÀÒÂÈß)ÎËÀÉÍÔÀÐÌ67.84
ÔÓÐÀÄÎÍÈÍ ÒÀÁ. 50ÌÃ ¹10 (ÁÎÐÈÑÎÂÑÊÈÉ ÇÌÏ, ÁÅËÀÐÓÑÜ)ÁÎÐÈÑÎÂÑÊÈÉ ÇÌÏ3.47
ÔÓÐÀÄÎÍÈÍ ÒÀÁ. 50ÌÃ ¹10 (ÈÐÁÈÒÑÊÈÉ ÕÔÇ, ÐÎÑÑÈß)ÈÐÁÈÒÑÊÈÉ ÕÔÇ1.73
ÔÓÐÀÇÎËÈÄÎÍ ÒÀÁ. 50ÌÃ ¹10 (ÁÎÐÈÑÎÂÑÊÈÉ ÇÌÏ, ÁÅËÀÐÓÑÜ)ÁÎÐÈÑÎÂÑÊÈÉ ÇÌÏ2.54
ÔÓÐÀÇÎËÈÄÎÍ ÒÀÁ. 50ÌÃ ¹10 (ÈÐÁÈÒÑÊÈÉ ÕÔÇ, ÐÎÑÑÈß)ÈÐÁÈÒÑÊÈÉ ÕÔÇ1.62
ÔÓÐÀÌÀÃ ÊÀÏÑ. 25ÌÃ ¹30 (ÎËÀÉÍÔÀÐÌ, ËÀÒÂÈß)ÎËÀÉÍÔÀÐÌ191.26
ÔÓÐÀÌÀÃ ÊÀÏÑ. 50ÌÃ ¹30 (ÎËÀÉÍÔÀÐÌ, ËÀÒÂÈß)ÎËÀÉÍÔÀÐÌ272.74
ÔÓÐÀÖÈËÈÍ Ð-Ð Ä/ÍÀÐÓÆÍ.ÏÐÈÌ. ÑÏÈÐÒ. 1:1500 0,067% 10ÌË ¹1 (ßÐÎÑËÀÂÑÊÀß ÔÀÐÌ.ÔÀÁÐÈÊÀ, ÐÎÑÑÈß)ßÐÎÑËÀÂÑÊÀß ÔÀÐÌ.ÔÀÁÐÈÊÀ5.09
ÔÓÐÀÖÈËÈÍ ÒÀÁ. 20ÌÃ ¹10 (ÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ, ÐÎÑÑÈß)ÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ1.7
ÔÓÐÀÖÈËÈÍ ÒÀÁ. 20ÌÃ ¹10 (ÈÐÁÈÒÑÊÈÉ ÕÔÇ, ÐÎÑÑÈß)ÈÐÁÈÒÑÊÈÉ ÕÔÇ1.62
ÔÓÐÀÖÈËÈÍ ÒÀÁ. 20ÌÃ ¹10 (ÒÀÒÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ, ÐÎÑÑÈß)ÒÀÒÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ1.63
ÔÓÐÎÑÅÌÈÄ Ð-Ð Ä/ÈÍ. 1% 2ÌË ¹10 (ÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ, ÐÎÑÑÈß)ÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ11.09
ÔÓÐÎÑÅÌÈÄ Ð-Ð Ä/ÈÍ. 1% 2ÌË ¹10 (ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ, ÐÎÑÑÈß)ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ10.89
ÔÓÐÎÑÅÌÈÄ ÒÀÁ. 40ÌÃ ¹50 (SOPHARMA, ÁÎËÃÀÐÈß)SOPHARMA10.85
ÔÓÐÎÑÅÌÈÄ ÒÀÁ. 40ÌÃ ¹50 (ÁÈÎÑÈÍÒÅÇ, ÐÎÑÑÈß)ÁÈÎÑÈÍÒÅÇ8.94
ÔÓÐÎÑÅÌÈÄ ÒÀÁ. 40ÌÃ ¹50 (ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ, ÐÎÑÑÈß)ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ7.99
ÔÓÐÎÑÅÌÈÄ ÒÀÁ. 40ÌÃ ¹50 (ÔÀÐÌÑÒÀÍÄÀÐÒ-ÒÎÌÑÊÕÈÌÔÀÐÌ, ÐÎÑÑÈß)ÔÀÐÌÑÒÀÍÄÀÐÒ-ÒÎÌÑÊÕÈÌÔÀÐÌ9.52
ÔÓÖÈÄÈÍ Ã ÊÐÅÌ 15Ã ¹1 (LEO LABORATORIÓS LIMITED, ÈÐËÀÍÄÈß)LEO LABORATORIÓS LIMITED321.16
ÔÓÖÈÄÈÍ ÊÐÅÌ 2% 15Ã ¹1 (LEO LABORATORIÓS LIMITED, ÈÐËÀÍÄÈß)LEO LABORATORIÓS LIMITED286.25
ÔÓÖÈÄÈÍ ÌÀÇÜ 2% 15Ã ¹1 (LEO PHARMACEUTICAL PRODUCTS, ÄÀÍÈß)LEO PHARMACEUTICAL PRODUCTS286.25
ÔÓÖÈÊÎÐÒ ÊÐÅÌ 15Ã ¹1 (LEO LABORATORIÓS LIMITED, ÈÐËÀÍÄÈß)LEO LABORATORIÓS LIMITED321.16
ÔÓÖÈÒÀËÌÈÊ ÊÀÏËÈ ÃËÀÇÍÛÅ 1% 5Ã ¹1 (LEO PHARMACEUTICAL PRODUCTS, ÄÀÍÈß)LEO PHARMACEUTICAL PRODUCTS287.07





2001-2011 http://www.med.sgg.ru - öåíû íà ëåêàðñòâà, ìåäòåõíèêó, âñå äëÿ ñòîìàòîëîãèè, õèðóðãè÷åñêèé è äðóãîé ìåäèöèíñêèé èíñòðóìåíò è òåõíèêà, ôàðìàöåâòè÷åñêèå ïðåïàðàòû è ñóáñòàíöèè îò ïðîèçâîäèòåëåé è îïòîâûõ ïðîäàâöîâ â Ìîñêâå, Ñàíêò-Ïåòåðáóðãå è äðóãèõ ðåãèîíàõ.



Rambler's Top100 Rambler's Top100 Ðåéòèíã@Mail.ru